-
Indication Screening: Using Early Health Technology Assessment to Prioritize Potential Target Indications for Platform Health Technologies
Mar 10, 2025, 14:00 PM -
Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model
Mar 10, 2025, 14:00 PM -
Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire
Mar 10, 2025, 14:00 PM -
Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Protocol Biopsy and Non-Invasive Biomarkers for Monitoring Transplant Rejection Within One-Year Post-Kidney Transplants
Mar 10, 2025, 14:00 PM -
Use of Logistic Regression to Evaluate All-Cause Readmission and Acute Renal Failure Rates for Infrarenal Fixation Device Family with ePTFE (Device A) Versus Two Suprarenal Fixation Devices with DACRON Material (Device B and C)
Mar 10, 2025, 14:00 PM -
Utility Values From Individuals With Knee Osteoarthritis in the UK
Mar 10, 2025, 14:00 PM -
The Dynamic Nature of Network Meta-Analysis: How Data Updates Could Influence Health Technology Assessment
Mar 10, 2025, 14:00 PM -
Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders
Mar 10, 2025, 14:00 PM -
Clinical and Economic Outcomes of Ultrasonic Energy Devices Used in Patients Treated With Sleeve Gastrectomy
Mar 10, 2025, 14:00 PM -
Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis
Mar 10, 2025, 14:00 PM -
Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)
Mar 10, 2025, 14:00 PM -
Autism Spectrum Disorder Caregiver Healthcare Resource Utilization and Economic Burden: Results From the 2024 US National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives
Mar 10, 2025, 14:00 PM -
Increasing Costs of Hospitalizations for Multiple Myeloma in the United States: A Database Analysis on Aggregate Costs and Patient Subpopulations
Mar 10, 2025, 14:00 PM -
Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization Patterns Among Patients With Non-Small Cell Lung Cancer Treated With Amivantamab Monotherapy
Mar 10, 2025, 14:00 PM -
The Quantification of Efficacy and Accuracy for Screening and Data Extraction in Perinatal Mood and Anxiety Disorders Studies: A Comparative Analysis of Traditional vs. GenAI-Powered Approaches
Mar 10, 2025, 14:00 PM -
The Cost of Managing Postpartum Hemorrhage: An Analysis by a Brazilian Health Insurer
Mar 10, 2025, 14:00 PM -
An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)
Mar 10, 2025, 14:00 PM
